SIGN UP
LOG IN
C
CHRS
Coherus Bioscien
0.76
-0.01-0.91%After Hours: 0.7700 +0.0090 +1.18%19:59 05/16 EDT
OPEN/PREV CLOSE0.7701/0.7680
TODAY RANGE0.7511-0.8376
VOL1.61M
MARKET CAP88.23M
52 WEEK RANGE0.6603-2.430
AVG VOL (3M)1.88M
% TURNOVER1.39%
TURNOVER--
P/E (TTM)-0.6715
% RANGE11.26%
EPS(TTM)-1.1333
P/E(FORWARD)-0.6670
P/B-0.4808
BVPS-1.5829
DIVIDEND--
P/S0.3296
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP80.15M
SHARES OUTSTANDING115.93M
NEXT EARNINGS08/06-08/11
FREE FLOAT105.32M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Biotech Alert: Searches spiking for these stocks today
Benzinga·4d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press release·5d ago
Coherus BioSciences, Inc. FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2025
Dow Jones·5d ago
*Coherus BioSciences 1Q Rev $7.6M >CHRS
Seeking Alpha·5d ago
Coherus BioSciences Non-GAAP EPS of -$0.35, revenue of $7.6M
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.